Evolving Treatment Strategies in Small Cell Lung Cancer - Episode 1

Importance of Early Referral and Diagnosis in Small-Cell Lung Cancer

June 26, 2023

Taofeek K. Owonikoko, MD, PhD, Anne Chiang, MD, PhD, Yale Cancer Center, Jacob Sands, MD, Dana-Farber Cancer Institute, Konstantinos Leventakos, MD, PhD Mayo Clinic

Expert oncologists provide an overview of the landscape surrounding small-cell lung cancer and highlight the importance of early referral and diagnosis for overall patient outcomes.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

Now Viewing

EP. 1: Importance of Early Referral and Diagnosis in Small-Cell Lung Cancer

EP. 2: Impact of Disease Staging on Prognosis and Treatment in SCLC

EP. 3: Evolving Role of Biomarkers in SCLC

EP. 4: Patient Scenario 1: Newly Diagnosed ES-SCLC With Presence of Hepatic and Brain Metastases

EP. 5: Expert Insights on First-line Treatment Strategies in SCLC

EP. 6: CASPIAN: Long-Term Follow-up Data and Potential Predictors for Treatment Outcomes

EP. 7: Combination Therapy Approaches With Chemotherapy and Immunotherapy in ES-SCLC

EP. 8: ADRIATIC Trial and Investigational Treatment Approaches for Limited-Stage SCLC

EP. 9: Patient Scenario 2: 1L Management of ES-SCLC Positive for Synaptophysin With a Ki-67 Score of 90%

EP. 10: Real World Data for Combination Strategies With Chemotherapy and Immunotherapy in ES-SCLC

EP. 11: Patient Scenario 3: 2L Lurbinectedin Following 1L Combination IO Chemotherapy

EP. 12: Evolving Treatment Strategies for SCLC in the Second-Line Setting and Beyond

EP. 13: LAGOON and IMFORTE Trials: Data Updates and Expert Insights

EP. 14: 2L Dosing Considerations and Management Strategies for SCLC

EP. 15: Novel Treatment Approaches for SCLC and Future Perspectives